I've been trading and investing in this stock since 2003. It's only drug is a novel treatment for cancer that teaches the body to fight cancer from within (highly simplified). The treatment will change how cancer is treated, moving away from Chemo, in which you almost kill the patient to kill the cancer. This treatment only leaves flu-like symptoms and gets more effective as time passes: It is the potential cure for cancer.
After being denied approval despite two positive clinical trials, Dendreon showed substantially positive results, well above and beyond the FDA's stated requirements for survivability. For those of you with family members suffering through Prostate cancer, there is a light at the end of the tunnel.
The company has stated that they intend to use this technology to target breast cancer, colon cancer, etc. This is a paradigm shift in cancer treatment.
Congrats to DNDN, congrats to the patients who have an option to survive, congrats to the long-term investors who have funded this company's life-saving treatment.
After being denied approval despite two positive clinical trials, Dendreon showed substantially positive results, well above and beyond the FDA's stated requirements for survivability. For those of you with family members suffering through Prostate cancer, there is a light at the end of the tunnel.
The company has stated that they intend to use this technology to target breast cancer, colon cancer, etc. This is a paradigm shift in cancer treatment.
Congrats to DNDN, congrats to the patients who have an option to survive, congrats to the long-term investors who have funded this company's life-saving treatment.